codethyline bepb 5 mg comp.
bepharbel manufacturing sa-nv - chlorhydrate d'ethylmorphine 5 mg - comprimé - 5 mg - chlorhydrate d'ethylmorphine 5 mg - ethylmorphine
dacepton 5 mg/ml sol. perf. s.c. flac.
ever neuro pharma gmbh - chlorhydrate d'apomorphine 5 mg/ml - solution pour perfusion - 5 mg/ml - chlorhydrate d'apomorphine 5 mg/ml - apomorphine
dacepton 10 mg/ml sol. inj. s.c. cart.
ever neuro pharma gmbh - chlorhydrate d'apomorphine 10 mg - solution injectable en cartouche - 10 mg/ml - chlorhydrate d'apomorphine 10 mg/ml - apomorphine
tussethyl 1,33 mg/ml sirop
kela pharma sa-nv - chlorhydrate d'ethylmorphine 1,33 mg/ml - eq. ethylmorphine 1,33 mg/ml - sirop - 1,33 mg/ml - chlorhydrate d'ethylmorphine 1.33 mg/ml - ethylmorphine
apovomin 3 mg/ml sol. inj. s.c. flac.
dechra regulatory b.v. - chlorhydrate d'apomorphine 3 mg/ml - eq. apomorphine 2,56 mg/ml - solution injectable - 3 mg/ml - chlorhydrate d'apomorphine 3 mg/ml - apomorphine - chien
emedog 1 mg/ml sol. inj. s.c. amp.
domes pharma - chlorhydrate d'apomorphine 1,17 mg/ml - eq. apomorphine 1 mg/ml - solution injectable - 1 mg/ml - chlorhydrate d'apomorphine 1.17 mg/ml - apomorphine - chien
apomorphine kalceks 5 mg/ml, solution pour perfusion
as kalceks - chlorhydrate d'apomorphine hémihydraté - solution - 5 mg - composition pour 1 ml de solution > chlorhydrate d'apomorphine hémihydraté : 5 mg - antiparkinsonien dopaminergique, agents dopaminergiques, agonistes dopaminergiques
ephydion, comprimé enrobé
cilfa developpement - chlorhydrate d'éthylmorphine - comprimé - 8,000 mg - composition pour un comprimé > chlorhydrate d'éthylmorphine : 8,000 mg > benzoate de sodium : 80,000 mg > grindélia (extrait mou de) : 12,500 mg - antitussif opiace
ephydion, solution buvable
cilfa developpement - chlorhydrate d'éthylmorphine - solution - 0,800 g - composition pour 100 ml > chlorhydrate d'éthylmorphine : 0,800 g > benzoate de sodium : 0,200 g > grindélia (extrait de) (fluide) : 0,400 g - antitussif opiace
vildagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabète sucré, type 2 - les médicaments utilisés dans le diabète - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 et 5. 1 pour les données disponibles sur différentes combinaisons).